Very Long Term Follow Up A Phase Ii Study Of Post-Remission Subcutaneous (Sc) Azacitidine (Aza) In Patients With Aml Post-Mds Or Higher-Risk (Hr) Mds

BLOOD(2020)

引用 0|浏览31
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要